Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy

Lung Cancer

Volumn 55, Issue 3, 2007, Pages 319-327

  Carvalho, Heloisa de Andrade ^a   Gonçalves, Silmara Luci Vernúcio ^a   Pedreira Jr , Wilson ^b   Gregório, Marcelo Gervilla ^b   de Castro, Isac ^b   Aisen, Salim ^a  

^a Division of Oncology   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Complications; Endobronchial brachytherapy; High dose rate; Irradiated volumes; Lung neoplasms; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CAUSE OF DEATH; CONTROLLED STUDY; FATALITY; FEMALE; HEMOPTYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; RISK FACTOR; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BRONCHIAL NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HEMOPTYSIS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS;

EID: 33847664216     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.10.015     Document Type: Article

References (34)

1. Harber P., and Stout R. High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indication. Thorax 51 (1996) 345-347
2. Mehta M.P., Speiser B.L., and Macha H.N. High dose rate brachytherapy for lung cancer. In: Nag S. (Ed). High dose rate brachytherapy: a textbook (1994), Futura, Armonk (NY) 295-319
3. Furuta M., Tsukiyama I., Ohno T., Katano S., Yokoi K., Sawafuji M., et al. Radiation therapy for roentogenographically occult lung cancer by external beam irradiation and endobronchial high dose rate brachytherapy. Lung Cancer 25 (1999) 183-189
4. Marsiglia H., Baldeyrou P., Lartigau E., Briot E., Haie-Meder C., Le Chevalier T., et al. High dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 47 (2000) 665-672
5. Pérol M., Caliandro R., Pommier P., Malet C., Montbarbon X., Carrie C., et al. Curative irradiation of limited endobronchial carcinoma with high-dose rate brachytherapy. Results of a pilot study. Chest 111 (1997) 1417-1423
6. Tredaniel J., Hennequin C., Zalcman G., Walters S., Hommasson J.P., Maylin C., et al. Prolonged survival after high dose rate endobronchial radiation for malignant airway obstruction. Chest 105 (1994) 767-772
7. Carvalho H.A., Aisen S., Chavantes M.C., Pedreira Jr. W.L., Takagaki T.Y., Haddad C.M.K., et al. High dose-rate endobronchial brachytherapy associated or not with previous Nd-YAG lasertherapy for lung cancer: results and complications of a prospective study (Abstr.). Lung Cancer 18 Suppl. 1 (1997) 134
8. Gauwitz M., Ellerbroek N., Komaki R., Putnam Jr. J.B., Ryan M.B., DeCaro L., et al. High dose rate endobronchial irradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 23 (1992) 397-400
9. Gustafson G., Vicini F., Freedman L., Johnston E., Edmunson G., Sherman S., et al. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies. Cancer 75 (1995) 2345-2350
10. Kelly J.F., Delclos M.E., Morice R.C., Huaringa A., Allen P.K., and Komaki R. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 48 (2000) 697-702
11. Macha H.N., Wahlers B., Reichle C., and von Zwehl D. Endobronchial radiation therapy for obstructing malignancies: ten years experience with Iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients. Lung 173 (1995) 271-280
12. Speiser B.L., and Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 25 (1993) 579-587
13. Taulelle M., Chauvet B., Vincent P., Felix Faure C., and Reboul F. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 11 (1998) 162-168
14. Aygun C., Weiner S., Scariato A., Spearman D., and Stark L. Treatment of non-small cell lung cancer with external beam radiotherapy and high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 23 (1992) 127-132
15. Bedwinek J., Petty A., Bruton C., Sofield J., and Lee L. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 22 (1991) 23-30
16. Khanavkar B., Stern P., Alberti W., and Nakhosteen J.A. Complications associated with brachytherapy alone or with laser in lung cancer. Chest 99 (1991) 1062-1065
17. Speiser B., and Spratling L. Fatal hemoptysis complication or failure of treatment. Int J Radiat Oncol Biol Phys 25 (1993) 925
18. Sutedja G., Baris G., van Zandwijk N., and Postmus P.E. High dose-rate brachytherapy has a curative potencial in patients with intraluminal squamous cell lung cancer. Respiration 61 (1993) 167-168
19. 192Ir endobronchial implants. Int J Radiat Oncol Biol Phys 34 (1996) 917-922
20. Burt P.A., O'Driscoll B.R., Notley H.M., Barber P.V., and Stout R. Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron. Thorax 45 (1990) 765-768
21. Chang L.F., Horvath J., Peyton W., and Ling S.S. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiat Oncol Biol Phys 28 (1994) 589-596
22. Gollins S.W., Ryder W.D., Burt P.A., Barber P.V., and Stout R. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 39 (1996) 105-116
23. Hara R., Itami J., Aruga T., Kozuka T., Nakajima K., Yamashita H., et al. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies. Cancer 92 (2001) 2623-2627
24. Hennequin C., Tredaniel J., Chevret S., Durdux C., Dray M., Manoux D., et al. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis. Int J Radiat Oncol Biol Phys 42 (1998) 21-27
25. Huber R.M., Fischer R., Hautmann H., Pollinger B., Haussinger K., and Wendt T. Does additional brachytherapy improve the effect of external irradiation? A prospective randomized study in central lung tumors. Int J Radiat Oncol Biol Phys 38 (1997) 533-540
26. Langendijk J.A., Tjwa M.K., de Jong J.M., ten Velde G.P., and Wouters E.F. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?. Radiother Oncol 49 (1998) 175-183
27. Mehta M., Petereit D., Chosy L., Harmon M., Fowler J., Shahabi S., et al. Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. Int J Radiat Oncol Biol Phys 23 (1992) 133-139
28. Miller J.I., and Phillips T. Neodymium: YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma. Ann Thorac Surg 50 (1990) 190-196
29. Nori D., Allison R., Kaplan B., Samala E., Osian A., and Karbowitz S. High dose rate intraluminal irradiation in bronchogenic carcinoma. Chest 104 (1993) 1006-1011
30. Ornadel D., Duchesne G., Wall P., Nq A., and Hetzel M. Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer 16 (1997) 203-213
31. Seagren S., Harell J., and Horn H. High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. Chest 88 (1985) 810-814
32. Carvalho H.A., Aisen S., Gonçalves S.V., Pedreira Jr. W., Gregório M.G., Tucci M., et al. Fatal hemoptysis and high dose-rate endobronchial brachytherapy: is there any relationship with clinical or technical parameters? (Abstr.). Int J Radiat Oncol Biol Phys 51 Suppl. 1 (2001) 349
33. Vikram B., Deore S., Beitler J.J., Sood B., Mullokandov E., Kapulsky A., et al. The relationship between dose heterogeneity ("hot" spots) and complications following high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 43 (1999) 983-987
34. Nag S., Kelly J.F., Horton J.L., Komaki R., and Nori D. The American Brachytherapy Society recommendations for brachytherapy for carcinoma of the lung. Oncology (Willinston Park) 15 (2001) 371-381